Content and data provided by various third parties and Fidelity − Terms of Use

Stock Details

RELATED RESOURCES
Print Format
Change Text Size:

BRIEF-Meridian Bioscience Reports Record Second Quarter Fiscal 2022 Operating Results

BY Reuters
— 8:22 AM ET 05/06/2022

May 6 (Reuters) - Meridian Bioscience Inc (VIVO):

* MERIDIAN BIOSCIENCE REPORTS RECORD SECOND QUARTER FISCAL 2022 OPERATING RESULTS

* SEES FY ADJUSTED EARNINGS PER SHARE $1.30 TO $1.40

* Q2 REVENUE ROSE 30 PERCENT TO $111.2 MILLION

* SEES CONSOLIDATED FY NET REVENUE $330.0 MILLION TO $345.0 MILLION

* QTRLY EARNINGS PER SHARE $0.65

* QTRLY ADJUSTED EARNINGS PER SHARE $0.66 Source text for Eikon: Further company coverage:

Copyright © Reuters 2008. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

More vivo News
Copyright 1998–2022 FMR LLC. 
All rights reserved. 
Close